Dipeptidyl peptidase-4 inhibitor tablets enhancing incretin effects for type 2 diabetes. Purchased by endocrinology practices, institutional pharmacies, and distributors from API and finished dosage form manufacturers for use in metabolic disorder therapies across healthcare systems.